Skip to main content
Premium Trial:

Request an Annual Quote

Definiens IO-Panel

Definiens now offers its Immuno-Oncology Panel (IO-Panel) as part of its "Insights" services portfolio. The IO-Panel is designed to enable pharmaceutical immuno-oncology researchers to advance tissue-biomarker-dependent drug development and speed up clinical research. It combines Definiens' digital image analysis capabilites, powered by Tissue-Phenomics technology, which quantifies relevant spatial relations of different immuno and tumor cells within the context of the complete tissue architecture and tumor heterogeneity, the company said.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.